Latest News & Features
Americas
US biotechnology company BioMarin Pharmaceutical has agreed to settle its patent infringement lawsuit against Dr Reddy’s Laboratories centring on its Kuvan (sapropterin dihydrochloride) drug. 23 September 2015
Africa
More than 150 tonnes of counterfeit medicine have been seized in southern Africa. 22 September 2015
Americas
Acorda Therapeutics has sued rival Par Pharmaceutical accusing it of infringing patents related to multiple sclerosis treatment drug Ampyra. 21 September 2015
Americas
Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid. 18 September 2015
Americas
The US Food and Drug Administration has introduced a rule enabling it to destroy certain drugs that have been refused entry into the US. 17 September 2015
Americas
Researchers should keep in mind that broad claims applying the discovery of a biomarker and disease correlation are currently patentable in Europe but not in the US. Andrew Carridge and Neil Thornton of Reddie & Grose report. 17 September 2015
Americas
Many players are piling into the scrum surrounding the patent eligibility of CRISPR technology. Mercedes Meyer of Drinker Biddle & Reath discusses the legal implications of CRISPR as a potential groundbreaking foundation technology. 17 September 2015
Asia
The Indian Pharmaceutical Alliance has dropped its opposition to a patent application filed by Gilead Sciences covering its hepatitis C drug Sovaldi. 16 September 2015
Americas
A US appeals court has revived a dispute in which a lower court previously ruled that there should not be a trial to determine whether pharmaceutical company Hospira infringed three patents. 14 September 2015
Big Pharma
The English High Court has ruled that Pfizer’s second medical use patent covering its drug Lyrica (pregabalin) is invalid and that the pharmaceutical company is liable for making “groundless threats” of infringement. 11 September 2015